PASS - Piloting the Pharmacist Asthma Support Study
Research type
Research Study
Full title
The feasibility and acceptability of a pharmacist-led Perceptions and Practicalities Approach (PAPA) intervention for medication adherence in adult asthma patients
IRAS ID
216830
Contact name
R. Horne
Contact email
Sponsor organisation
Joint Research Office, University College London
Clinicaltrials.gov Identifier
Z6364106/2017/08/39, UCL Data Protection Registration
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
The health outcomes for people with asthma in the United Kingdom (UK) need improvement. Our research, supported by the National Institute of Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) North Thames and the Asthma UK Centre for Applied Research (AUKCAR), focuses on developing new ways to support people with asthma in taking their medication more consistently and improving their asthma control.
Based on previous research and theory, we developed a new asthma support programme that will help people take their preventer inhaler more consistently. It will be delivered by a pharmacist through two individual consultations at their local GP surgery. The first consultation (15 – 20 mins) will deliver the service and the second one (10 mins) takes place one month later to check on progress. The asthma support programme focuses on tailoring information and targeting counselling based on the needs/concerns of each individual participant. It is embedded in a normal asthma review, to make sure that patients do not miss out on standard asthma care. In this study, we want to test this new service to see if it is useful and valuable for people with asthma.
We will recruit adults with high risk asthma (18 and over) with a prescription for a preventer inhaler through two Clinical Commissioning Groups (CCGs) in London. Participants should be fluent in English and able to self-administer their inhaler. Everyone who participates will receive the new service. Before and after each consultation at the GP surgery, participants will be asked to fill in questionnaires about their preventer inhaler, asthma, and satisfaction with the service. A final set of questionnaires will be mailed to their home address 3 months after the first consultation, along with a prepaid return envelope. In case of non-response, the research team will follow-up over the telephone.
REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
17/LO/1965
Date of REC Opinion
14 Dec 2017
REC opinion
Further Information Favourable Opinion